TransMedics Group financials at a glance

+ Portfolio

The revenue of TransMedics Group is reported as 0.24162 billion Dollars in the fiscal year 2023. The earnings were 0.07 Dollars per share in 2023, which was 105.69 higher than 2022. And about -0.16488 billion Dollars are reported as free cash flow in the financials of TransMedics Group 2023. No dividends were paid to the shareholders of the TransMedics Group stock NasdaqGM:TMDX in the financial year 2023.

$241.62M

Revenue

$0.07

Earnings Per Share

63.77%

Gross Margin %

$-84.45M

Free Cash Flow

Revenue

241.62

Earnings Per Share

0.07

Gross Margin %

63.77

Free Cash Flow

-84.45

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018
Rev.	Revenue	N/A	$241.62M	$93.46M	$30.26M	$25.64M	$23.60M	$13.02M
GM %	Gross Margin %	66.14%	63.77%	69.84%	69.92%	64.88%	58.73%	44.05%
OM	Operating Margin	-5.68%	0.20%	-33.64%	-,130.29%	-,102.91%	-,125.42%	-,155.47%
EPS	Earnings Per Share	$-1.11	$0.07	$-1.23	$-1.60	$-1.16	$-2.36	$-5.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0
Sha.	Shares	N/AM	32.72M	32.2M	27.96M	27.37M	21.22M	4.89M
OCF	Operating Cash Flow	N/A	$-13.03M	$-45.82M	$-28.86M	$-30.27M	$-32.29M	$0.00M
FCF	Free Cash Flow	N/A	$-84.45M	$-57.72M	$-32.38M	$-30.72M	$-32.45M	$0.00M
FCFS	Free Cash Flow Per Share	$-5.11	$-5.91	$-1.95	$-1.17	$-1.24	$-2.28	$-19.43

TransMedics Group financials at a glance

Financials

Discover